Gadolinium promoted proliferation in mouse embryo fibroblast NIH3T3 cells through Rac and PI3K/Akt signaling pathways

BioMetals

Volumn 27, Issue 4, 2014, Pages 753-762

  Shen, Liming ^a   Yang, Aochu ^a   Yao, Pengwei ^b   Sun, Xiaohong ^b   Chen, Cheng ^a   Mo, Cuiping ^a   Shi, Lei ^b   Chen, Youjiao ^a   Liu, Qiong ^a  

^a SHENZHEN UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Gadolinium chloride; Nephrogenic systemic fibrosis; NIH3T3 cells; Proliferation

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; AMINOQUINOLINE DERIVATIVE; CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM CHLORIDE; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRIMIDINE DERIVATIVE; RAC1 PROTEIN; RAC1 PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE;

3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; DRUG EFFECTS; METABOLISM; MOUSE; PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CONTRAST MEDIA; CYTOSKELETON; GADOLINIUM; MICE; NEUROPEPTIDES; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84905111289     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9769-9     Document Type: Article

References (43)

1. Abraham JL, Thakral C (2008) Tissue distribution and kinetics of Gd and nephrogenic systemic fibrosis. Eur J Radiol 66(2):200-207
2. Anand-Apte B, Zetter BR, Viswanathan A, Qiu RG, Chen J, Ruggieri R, Symons M (1997) Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J Biol Chem 272:30688-30692 (Pubitemid 27527501)
3. Bongartz G (2007) Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA 20:57-62
4. Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56(1):27-30 (Pubitemid 44969309)
5. Chen HH, Zhao S, Song JG (2003) TGF-beta1 suppresses apoptosis via differential regulation of MAP kinases and ceramide production. Cell Death Differ 10(5):516-527 (Pubitemid 36656641)
6. Cowper SE (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 115(6):785-790
7. Cowper SE (2007) Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol 23:131-154
8. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxedema-like cutaneous diseases in renal dialysis patients. Lancet 356(9234):1000-1001
9. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23(5):383-393 (Pubitemid 32938907)
10. Daram SR, Cortese CM, Bastani B (2005) Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46(4):754-759 (Pubitemid 41383955)
11. DelPozo MA, Price LS, Alderson NB, Ren XD, Schwartz MA (2000) Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 19(9):2008-2014 (Pubitemid 30237576)
12. Ersoy H, Rybicki FJ (2007) Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26(5):1190-1197 (Pubitemid 350058285)
13. Frenzel T, Lengsfeld P, Schirmer H, Hütter J, Weinmann HJ (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 43(12):817-828
14. Fu LJ, Li JX, Yang XG, Wang K (2009) Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH3T3 cells. J Biol Inorg Chem 14(2):219-227
15. Gonzalez E, Kou R, Michel T (2006) Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. J Biol Chem 281(6):3210-3216 (Pubitemid 43845932)
16. Grobner T (2006) Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21(4):1104-1108
17. Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28:S28-S43
18. Haylor JL, Dencausse H, Vickers M, Idee JM, Slater D, Morcos SK (2009) Increased skin cellularity following Omniscan in rats with reduced renal function. Conference Abstract of ECR, 2009
19. High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56(1):21-26 (Pubitemid 46017000)
20. Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C (2008) Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology 248(2-3):77-88
21. Kalluri R, Sukhatme VP (2000) Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 9:413-418 (Pubitemid 30451697)
22. Kanal E, Broome DR, Martin DR, Thomsen HS (2008) Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 246(1):11-14
23. Li JX, Liu JC, Wang K, Yang XG (2010) Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells. J Biol Inorg Chem 15(4):547-557
24. 1 to S phase cell cycle transition by enhancing focal adhesion formation. J Biol Inorg Chem 17(3):375-385
25. Liu S, Kapoor M, Shi WX, Kennedy L, Denton CP, Glogauer M, Abraham DJ, Leask A (2008) Role of Rac1 in a bleomycininduced scleroderma model using fibroblast-specific Rac1-knockout mice. Arthritis Rheum 58:2189-2195 (Pubitemid 351988113)
26. Liu S, Kapoor M, Leask A (2009) Rac1 expression by fibroblasts is required for tissue repair in vivo. Am J Pathol 174:1847-1856
27. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192(1):1-15 (Pubitemid 34587382)
28. Newton BB, Jimenez SA (2009) Mechanism of NSF: new evidence challenging the prevailing theory. J Magn Reson Imaging 30(6):1277-1283
29. Pai SY, Kim C, Williams DA (2010) Rac GTPases in human diseases. Dis Markers 29(3-4):177-187
30. Penfield JG, Reilly RF Jr (2007) What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 3(12):654-668 (Pubitemid 350146964)
31. Shen LM, Liu Q, Ni JZ, Hong GY (2009) A proteomic investigation into the human cervical cancer cell line HeLa treated with dicitratoytterbium (III) complex. Chem Biol Interact 181:455-462
32. Shen LM, Lan ZY, Sun XH, Shi L, Liu Q, Ni JZ (2010) Proteomic analysis of lanthanum citrate-induced apoptosis in human cervical carcinoma SiHa cells. Biometals 23(6):1179-1189
33. Shi Y, Gou BD, Shi YL, Zhang TL, Wang K (2009) Lanthanum chloride suppresses hydrogen peroxide-enhanced calcification in rat calcifying vascular cells. Biometals 22(2):317-327
34. Swaminathan S, Arbiser JL, Hiatt KM, High W, Abul-Ezz S, Horn TD, Shah SV (2010) Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase. J Am Acad Dermatol 62(2):343-345
35. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG, Kanakura Y(2002) E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9(5):1017-1029 (Pubitemid 34626671)
36. Thakral C, Abraham JL (2009) Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis. J Cutan Pathol 36(12):1244-1254
37. Thomsen HS (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16(12):2619-2621
38. Ting WW, Stone MS, Madison KC, Kurtz K (2003) Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139(7):903-906 (Pubitemid 36898926)
39. Wang X, Huang J, Zhang TL, Wang K (2009) Cytoskeleton reorganization and FAK phosphorylation are involved in lanthanum (III)-promoted proliferation and differentiation in rat osteoblasts. Prog Nat Sci 19:331-335
40. Wang X, Gou BD, Wang K (2013) Gadolinium promoted angiogenesis involves the activation of PKCα/β2 and MAPKs in human umbilical vein endothelial cells. J Chin Pharmaceut Sci 22:71-76
41. Xu SW, Liu S, Eastwood M, Sonnylal S, Denton CP, Abraham DJ, Leask A (2009) Rac inhibition reverses the phenotype of fibrotic fibroblasts. PLoS One 4(10):e7438
42. Ye LH, Shi Z, Liu HX, Yang XD, Wang K (2011) Gadolinium induced apoptosis of human embryo liver L02 cell line by ROS-mediated AIF pathway. J Rare Earths 29(02):178-184
43. Zhang Y, Fu LJ, Li JX, Yang XG, Yang XD, Wang K (2009) Gadolinium promoted proliferation and enhanced survival in human cervical carcinoma cells. Biometals 22(3):511-519